{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:17:18Z","timestamp":1790281038195,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"crossref","award":["Maternity Leave Program"],"award-info":[{"award-number":["Maternity Leave Program"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["DFG RU5068"],"award-info":[{"award-number":["DFG RU5068"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Sex Differ"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The clinical course and outcome of many diseases differ between women and men, with women experiencing a higher prevalence and more severe pathogenesis of autoimmune diseases. The precise mechanisms underlying these sex differences still remain to be fully understood. IRF5 is a master transcription factor that regulates TLR\/MyD88-mediated responses to pathogen-associated molecular patterns (PAMPS) in DCs and B cells. B cells are central effector cells involved in autoimmune diseases via the production of antibodies and pro-inflammatory cytokines as well as mediating T cell help. Dysregulation of IRF5 expression has been reported in autoimmune diseases, including systemic lupus erythematosus, primary Sj\u00f6gren syndrome, and rheumatoid arthritis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In the current study, we analyzed whether the percentage of IRF5 positive B cells differs between women and men and assessed the resulting consequences for the production of inflammatory cytokines after TLR7- or TLR9 stimulation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The percentage of IRF5 positive B cells was significantly higher in B cells of women compared to men in both unstimulated and TLR7- or TLR9-stimulated B cells. B cells of women produced higher levels of TNF-\u03b1 in response to TLR9 stimulation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Taken together, our data contribute to the understanding of sex differences in immune responses and may identify IRF5 as a potential therapeutic target to reduce harmful B cell-mediated immune responses in women.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13293-023-00495-x","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T07:02:57Z","timestamp":1677049377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Sex differences in the percentage of IRF5 positive B cells are associated with higher production of TNF-\u03b1 in women in response to TLR9 in humans"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4905-4646","authenticated-orcid":false,"given":"Claudia","family":"Beisel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Jordan-Paiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"K\u00f6llmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika Elise","family":"Ahrenstorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Padoan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Barkhausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marylyn M.","family":"Addo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Altfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"key":"495_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/23.5.1078","author":"MS Green","year":"1994","unstructured":"Green MS, Shohat T, Lerman Y, Cohen D, Slepon R, Duvdevani P, et al. Sex differences in the humoral antibody response to live measles vaccine in young adults. Int J Epidemiol. 1994. https:\/\/doi.org\/10.1093\/ije\/23.5.1078.","journal-title":"Int J Epidemiol"},{"key":"495_CR2","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-48-12-1075","author":"LA Mitchell","year":"1999","unstructured":"Mitchell LA. Sex differences in antibody- and cell-mediated immune response to rubella re-immunisation. J Med Microbiol. 1999. https:\/\/doi.org\/10.1099\/00222615-48-12-1075.","journal-title":"J Med Microbiol"},{"key":"495_CR3","doi-asserted-by":"publisher","unstructured":"Olsen NJ, Kovacs WJ. Gonadal steroids and immunity*. Endocr Rev. 1996;17(4). https:\/\/doi.org\/10.1210\/edrv-17-4-369.","DOI":"10.1210\/edrv-17-4-369"},{"key":"495_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.90","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016. https:\/\/doi.org\/10.1038\/nri.2016.90.","journal-title":"Nat Rev Immunol"},{"key":"495_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70049-9","author":"SL Klein","year":"2010","unstructured":"Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 2010. https:\/\/doi.org\/10.1016\/S1473-3099(10)70049-9.","journal-title":"Lancet Infect Dis"},{"key":"495_CR6","doi-asserted-by":"publisher","unstructured":"Lotter H, Altfeld M. Sex differences in immunity. Semin Immunopathol. 2019;41(2). https:\/\/doi.org\/10.1007\/s00281-018-00728-x.","DOI":"10.1007\/s00281-018-00728-x"},{"key":"495_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/ni0901-777","author":"CC Whitacre","year":"2001","unstructured":"Whitacre CC. Sex differences in autoimmune disease. Nat Immunol. 2001. https:\/\/doi.org\/10.1038\/ni0901-777.","journal-title":"Nat Immunol"},{"key":"495_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004272","author":"KD Boodhoo","year":"2016","unstructured":"Boodhoo KD, Liu S, Zuo X. Impact of sex disparities on the clinical manifestations in patients with systemic lupus erythematosus. Medicine. 2016. https:\/\/doi.org\/10.1097\/MD.0000000000004272.","journal-title":"Medicine"},{"key":"495_CR9","doi-asserted-by":"publisher","unstructured":"Bugatti S, Codullo V, Caporali R, Montecucco C. B cells in rheumatoid arthritis. Autoimmun Rev. 2007;7(2). https:\/\/doi.org\/10.1016\/j.autrev.2007.02.017.","DOI":"10.1016\/j.autrev.2007.02.017"},{"key":"495_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2009.10.011","author":"E Nashi","year":"2010","unstructured":"Nashi E, Wang Y, Diamond B. The role of B cells in lupus pathogenesis. Int J Biochem Cell Biol. 2010. https:\/\/doi.org\/10.1016\/j.biocel.2009.10.011.","journal-title":"Int J Biochem Cell Biol"},{"key":"495_CR11","doi-asserted-by":"publisher","unstructured":"D\u00f6rner T, Jacobi AM, Lipsky PE. B cells in autoimmunity. Arthritis Res Ther. 2009;11(5). https:\/\/doi.org\/10.1186\/ar2780.","DOI":"10.1186\/ar2780"},{"key":"495_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2018.1","author":"G Nocturne","year":"2018","unstructured":"Nocturne G, Mariette X. B cells in the pathogenesis of primary Sj\u00f6gren syndrome. Nat Rev Rheumatol. 2018. https:\/\/doi.org\/10.1038\/nrrheum.2018.1.","journal-title":"Nat Rev Rheumatol."},{"key":"495_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/nri1900","author":"K Honda","year":"2006","unstructured":"Honda K, Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol. 2006. https:\/\/doi.org\/10.1038\/nri1900.","journal-title":"Nat Rev Immunol"},{"key":"495_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-00092-2","author":"DSW Lee","year":"2021","unstructured":"Lee DSW, Rojas OL, Gommerman JL. B cell depletion therapies in autoimmune disease: advances and mechanistic insights. Nat Rev Drug Discov. 2021. https:\/\/doi.org\/10.1038\/s41573-020-00092-2.","journal-title":"Nat Rev Drug Discov."},{"key":"495_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxy032","author":"T Ban","year":"2018","unstructured":"Ban T, Sato GR, Tamura T. Regulation and role of the transcription factor IRF5 in innate immune responses and systemic lupus erythematosus. Int Immunol. 2018. https:\/\/doi.org\/10.1093\/intimm\/dxy032.","journal-title":"Int Immunol"},{"key":"495_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/nri1957","author":"A Marshak-Rothstein","year":"2006","unstructured":"Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol. 2006. https:\/\/doi.org\/10.1038\/nri1957.","journal-title":"Nat Rev Immunol"},{"issue":"7030","key":"495_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nature03308","volume":"434","author":"A Takaoka","year":"2005","unstructured":"Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T, et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature. 2005;434(7030):243\u20139.\u00a0https:\/\/doi.org\/10.1038\/nature03308.","journal-title":"Nature"},{"key":"495_CR18","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.96795","author":"V Gies","year":"2018","unstructured":"Gies V, Schickel JN, Jung S, Joublin A, Glauzy S, Knapp AM, et al. Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus. JCI Insight. 2018. https:\/\/doi.org\/10.1172\/jci.insight.96795.","journal-title":"JCI Insight."},{"issue":"1","key":"495_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.trsl.2015.06.018","volume":"167","author":"HL Eames","year":"2016","unstructured":"Eames HL, Corbin AL, Udalova IA. Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease. Transl Res. 2016;167(1):167\u201382.","journal-title":"Transl Res"},{"key":"495_CR20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1005599107","author":"DA Savitsky","year":"2010","unstructured":"Savitsky DA, Yanai H, Tamura T, Taniguchi T, Honda K. Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus. Proc Natl Acad Sci. 2010. https:\/\/doi.org\/10.1073\/pnas.1005599107.","journal-title":"Proc Natl Acad Sci"},{"key":"495_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/ng1782","author":"RR Graham","year":"2006","unstructured":"Graham RR, Kozyrev SV, Baechler EC, Reddy MVPL, Plenge RM, Bauer JW, et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet. 2006. https:\/\/doi.org\/10.1038\/ng1782.","journal-title":"Nat Genet"},{"key":"495_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/08830185.2018.1469629","author":"A Kaur","year":"2018","unstructured":"Kaur A, Lee LH, Chow SC, Fang CM. IRF5-mediated immune responses and its implications in immunological disorders. Int Rev Immunol. 2018. https:\/\/doi.org\/10.1080\/08830185.2018.1469629.","journal-title":"Int Rev Immunol"},{"issue":"11","key":"495_CR23","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.4049\/jimmunol.1501684","volume":"195","author":"M Griesbeck","year":"2015","unstructured":"Griesbeck M, Ziegler S, Laffont S, Smith N, Chauveau L, Tomezsko P, et al. Sex differences in plasmacytoid dendritic cell levels of IRF5 drive higher IFN-production in women. J Immunol. 2015;195(11):5327\u201336.","journal-title":"J Immunol"},{"issue":"2","key":"495_CR24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jim.2008.09.007","volume":"339","author":"A Meier","year":"2008","unstructured":"Meier A, Fisher A, Sidhu HK, Chang JJ, Wen TF, Streeck H, et al. Rapid loss of dendritic cell and monocyte responses to TLR ligands following venipuncture. J Immunol Methods. 2008;339(2):132\u201340.","journal-title":"J Immunol Methods"},{"issue":"16","key":"495_CR25","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1128\/MCB.22.16.5721-5740.2002","volume":"22","author":"BJ Barnes","year":"2002","unstructured":"Barnes BJ, Kellum MJ, Field AE, Pitha PM. Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol Cell Biol. 2002;22(16):5721\u201340.","journal-title":"Mol Cell Biol"},{"key":"495_CR26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-263020","author":"T Krausgruber","year":"2010","unstructured":"Krausgruber T, Saliba D, Ryzhakov G, Lanfrancotti A, Blazek K, Udalova IA. IRF5 is required for late-phase TNF secretion by human dendritic cells. Blood. 2010. https:\/\/doi.org\/10.1182\/blood-2010-01-263020.","journal-title":"Blood"},{"key":"495_CR27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800221","author":"KT Chow","year":"2018","unstructured":"Chow KT, Wilkins C, Narita M, Green R, Knoll M, Loo YM, et al. Differential and overlapping immune programs regulated by IRF3 and IRF5 in plasmacytoid dendritic cells. J Immunol. 2018. https:\/\/doi.org\/10.4049\/jimmunol.1800221.","journal-title":"J Immunol"},{"key":"495_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/srep31002","author":"D Li","year":"2016","unstructured":"Li D, De S, Li D, Song S, Matta B, Barnes BJ. Specific detection of interferon regulatory factor 5 (IRF5): a case of antibody inequality. Sci Rep. 2016. https:\/\/doi.org\/10.1038\/srep31002.","journal-title":"Sci Rep"},{"issue":"17","key":"495_CR29","doi-asserted-by":"publisher","first-page":"17005","DOI":"10.1074\/jbc.M412584200","volume":"280","author":"A Schoenemeyer","year":"2005","unstructured":"Schoenemeyer A, Barnes BJ, Mancl Margo E, Latz E, Goutagny N, Pitha PM, et al. The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling. J Biol Chem. 2005;280(17):17005\u201312.","journal-title":"J Biol Chem"},{"key":"495_CR30","doi-asserted-by":"publisher","unstructured":"Steinhagen F, McFarland AP, Rodriguez LG, Tewary P, Jarret A, Savan R, et al. IRF-5 and NF-\u03baB p50 co-regulate IFN-\u03b2 and IL-6 expression in TLR9-stimulated human plasmacytoid dendritic cells. Eur J Immunol. 2013;43(7). https:\/\/doi.org\/10.1002\/eji.201242792.","DOI":"10.1002\/eji.201242792"},{"issue":"1","key":"495_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41421-019-0137-3","volume":"5","author":"Z Shi","year":"2019","unstructured":"Shi Z, Zhang Q, Yan H, Yang Y, Wang P, Zhang Y, et al. More than one antibody of individual B cells revealed by single-cell immune profiling. Cell Discov. 2019;5(1):64.","journal-title":"Cell Discov"},{"issue":"2","key":"495_CR32","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.4238\/2014.June.16.6","volume":"13","author":"L Tang","year":"2014","unstructured":"Tang L, Chen B, Ma B, Nie S. Association between IRF5 polymorphisms and autoimmune diseases: a meta-analysis. Genet Mol Res. 2014;13(2):4473\u201385.","journal-title":"Genet Mol Res"},{"issue":"9","key":"495_CR33","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1111\/febs.14654","volume":"286","author":"H Almuttaqi","year":"2019","unstructured":"Almuttaqi H, Udalova IA. Advances and challenges in targeting IRF5, a key regulator of inflammation. FEBS J. 2019;286(9):1624\u201337.","journal-title":"FEBS J"},{"issue":"12","key":"495_CR34","doi-asserted-by":"publisher","first-page":"6700","DOI":"10.1172\/JCI120288","volume":"130","author":"S Song","year":"2020","unstructured":"Song S, De S, Nelson V, Chopra S, LaPan M, Kampta K, et al. Inhibition of IRF5 hyperactivation protects from lupus onset and severity. J Clin Investig. 2020;130(12):6700\u201317.","journal-title":"J Clin Investig"},{"issue":"1","key":"495_CR35","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1038\/s41467-021-24609-4","volume":"12","author":"T Ban","year":"2021","unstructured":"Ban T, Kikuchi M, Sato GR, Manabe A, Tagata N, Harita K, et al. Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease. Nat Commun. 2021;12(1):4379.","journal-title":"Nat Commun"},{"issue":"Suppl 1","key":"495_CR36","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/gerona\/glu057","volume":"69","author":"C Franceschi","year":"2014","unstructured":"Franceschi C, Campisi J. Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases. J Gerontol A Biol Sci Med Sci. 2014;69(Suppl 1):S4-9.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"495_CR37","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.4049\/jimmunol.0901022","volume":"184","author":"A Panda","year":"2010","unstructured":"Panda A, Qian F, Mohanty S, van Duin D, Newman FK, Zhang L, et al. Age-Associated Decrease in TLR Function in Primary Human Dendritic Cells Predicts Influenza Vaccine Response. J Immunol. 2010;184(5):2518\u201327.","journal-title":"J Immunol"},{"issue":"2","key":"495_CR38","doi-asserted-by":"publisher","first-page":"970","DOI":"10.4049\/jimmunol.178.2.970","volume":"178","author":"D van Duin","year":"2007","unstructured":"van Duin D, Mohanty S, Thomas V, Ginter S, Montgomery RR, Fikrig E, et al. Age-Associated Defect in Human TLR-1\/2 Function. J Immunol. 2007;178(2):970\u20135.","journal-title":"J Immunol"},{"key":"495_CR39","first-page":"8","volume":"10","author":"S De","year":"2018","unstructured":"De S, Zhang B, Shih T, Singh S, Winkler A, Donnelly R, et al. B Cell-Intrinsic Role for IRF5 in TLR9\/BCR-Induced Human B Cell Activation, Proliferation, and Plasmablast Differentiation. Front Immunol. 2018;10:8.","journal-title":"Front Immunol"},{"key":"495_CR40","doi-asserted-by":"publisher","unstructured":"Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S, et al. Sex differences in the Toll-like receptor\u2013mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med. 2009;15(8).  https:\/\/doi.org\/10.1038\/nm.2004.","DOI":"10.1038\/nm.2004"},{"key":"495_CR41","doi-asserted-by":"publisher","unstructured":"Bergh\u00f6fer B, Frommer T, Haley G, Fink L, Bein G, Hackstein H. TLR7 Ligands Induce Higher IFN-\u03b1 Production in Females. J Immunol. 2006;177(4). https:\/\/doi.org\/10.4049\/jimmunol.178.7.4072.","DOI":"10.4049\/jimmunol.178.7.4072"},{"key":"495_CR42","doi-asserted-by":"publisher","unstructured":"Seillet C, Laffont S, Tr\u00e9molli\u00e8res F, Rouqui\u00e9 N, Ribot C, Arnal JF, et al. The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor \u03b1 signaling. Blood. 2012;119(2). https:\/\/doi.org\/10.1182\/blood-2011-08-371831.","DOI":"10.1182\/blood-2011-08-371831"},{"key":"495_CR43","doi-asserted-by":"publisher","unstructured":"Volpi C, Fallarino F, Pallotta MT, Bianchi R, Vacca C, Belladonna ML, et al. High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9\u2013TRIF pathway. Nat Commun. 2013;4(1). https:\/\/doi.org\/10.1038\/ncomms2874.","DOI":"10.1038\/ncomms2874"},{"key":"495_CR44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.semcancer.2019.05.002","volume":"64","author":"MC Patra","year":"2020","unstructured":"Patra MC, Shah M, Choi S. Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases. Semin Cancer Biol. 2020;64:61\u201382.\u00a0https:\/\/doi.org\/10.1016\/j.semcancer.2019.05.002.","journal-title":"Semin Cancer Biol"},{"key":"495_CR45","doi-asserted-by":"publisher","unstructured":"Torcia MG, Nencioni L, Clemente AM, Civitelli L, Celestino I, Limongi D, et al. Sex differences in the response to viral infections: TLR8 and TLR9 ligand stimulation induce higher IL10 production in males. PLoS One. 2012;7(6). https:\/\/doi.org\/10.1371\/journal.pone.0039853.","DOI":"10.1371\/journal.pone.0039853"},{"key":"495_CR46","doi-asserted-by":"publisher","unstructured":"Taylor PC, Feldmann M. Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat Rev Rheumatol. 2009;5(10). https:\/\/doi.org\/10.1038\/nrrheum.2009.181.","DOI":"10.1038\/nrrheum.2009.181"},{"key":"495_CR47","doi-asserted-by":"publisher","unstructured":"Taylor PC. Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases. Curr Opin Pharmacol. 2010;10(3). https:\/\/doi.org\/10.1016\/j.coph.2010.01.005.","DOI":"10.1016\/j.coph.2010.01.005"},{"key":"495_CR48","doi-asserted-by":"publisher","unstructured":"Asai K, Hiki N, Mimura Y, Ogawa T, Unou K, Kaminishi M. Gender differences in cytokine secretion by human peripheral blood mononuclear cells: role of estrogen in modulating LPS-induced cytokine secretion in an ex vivo septic model. Shock. 2001;16(5). https:\/\/doi.org\/10.1097\/00024382-200116050-00003.","DOI":"10.1097\/00024382-200116050-00003"},{"key":"495_CR49","doi-asserted-by":"publisher","unstructured":"Aomatsu M, Kato T, Kasahara E, Kitagawa S. Gender difference in tumor necrosis factor-\u03b1 production in human neutrophils stimulated by lipopolysaccharide and interferon-\u03b3. Biochem Biophys Res Commun. 2013;441(1). https:\/\/doi.org\/10.1016\/j.bbrc.2013.10.042.","DOI":"10.1016\/j.bbrc.2013.10.042"}],"container-title":["Biology of Sex Differences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-023-00495-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13293-023-00495-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-023-00495-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T19:05:00Z","timestamp":1677092700000},"score":1,"resource":{"primary":{"URL":"https:\/\/bsd.biomedcentral.com\/articles\/10.1186\/s13293-023-00495-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["495"],"URL":"https:\/\/doi.org\/10.1186\/s13293-023-00495-x","relation":{},"ISSN":["2042-6410"],"issn-type":[{"value":"2042-6410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,22]]},"assertion":[{"value":"31 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of the \u00c4rztekammer Hamburg (PV4780). Written informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The corresponding author (CB) states on behalf of all authors that there is no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}